-
31 January 2017 Editor Tony Kaye asks economics writer Callam Pickering what's behind the strength of the Australian dollar.
-
31 January 2017 Virtus has lost market share in its key state, but there are other things to like about this IVF provider.
-
30 January 2017 To make room for new companies we cease coverage on a number of businesses from time to time. Here is this year's selection.
-
30 January 2017 Sonic has acquired a new pathology lab in Germany.
-
30 January 2017 The share price of serviced office provider Servcorp has fallen 20% following a profit warning.
-
30 January 2017 To help you navigate the coming company results, John Addis asks the team what they’re looking out for.
-
27 January 2017 Australia's largest rail freight operator uses too much capital and there's not much growth on the horizon.
-
25 January 2017 BKI's portfolio manager addresses a flat performance by the large-cap Australian equities portfolio, and gives his views on banks and the dollar.
-
25 January 2017 ResMed has announced another quarter of decent sales growth failing to translate into earnings.
-
24 January 2017 CIMIC, a serial acquirer in the mining services space, has lobbed a bid for Macmahon.
-
24 January 2017 Analyst Jon Mills sits down with iSelect CEO Scott Wilson to discuss the group's operations.
-
24 January 2017 The conglomerate’s Resources business has staged a remarkable turnaround but Coles is losing some sheen.
-
23 January 2017 We look forward to this week's inflation figures, the US GDP figures and the long-term outlook for the Trump presidency.
-
23 January 2017 Investors are overstating the impact of a Trump presidency and missing one of the biggest risks. Here’s how to deal with it.
-
23 January 2017 Brambles has lowered its expectation for full-year profit due to pricing pressure and poor sales.
-
23 January 2017 Despite declining revenues and declining profits, Fleetwood's share price rose 60% last year. Does the investment case still stack up?
-
19 January 2017 Co-founder Greg Roebuck is stepping down as managing director, to be replaced by chief operating officer Cameron McIntyre. Is it time to worry?
-
19 January 2017 This blood products maker has lifted expectations for full-year net profit.
-
18 January 2017 Sirtex investors have been getting whiplash in recent months. Graham Witcomb considers some possible futures for the company.
-
17 January 2017 By signing a crippling supply agreement with Fonterra, Bellamy's has put its destiny in the hands of others.